Keyphrases
White Matter
100%
Neuroinflammation
100%
Chorioamnionitis
100%
Ovine Fetus
100%
Injury Timing
100%
Immunoreactivity
50%
Intra-amniotic
50%
Receptor Expression
50%
Preterm Brain Injury
50%
Erythropoietin
50%
Perinatal Infection
50%
Interleukin-8
25%
Interleukin-6
25%
Clinical Trials
25%
Preterm Delivery
25%
Gestational Age
25%
Risk Factors
25%
Preterm Infants
25%
Preterm Birth
25%
Lipopolysaccharide
25%
Inflammatory Markers
25%
Perinatal Brain Injury
25%
Neurodevelopmental Outcome
25%
Cell Death
25%
Cyclooxygenase-2
25%
Caspase-3
25%
Neuronal Injury
25%
Brain Development
25%
Spatiotemporal
25%
Fetal Brain
25%
Peripheral Immune Activation
25%
Post-mortem Analysis
25%
Neuroprotective Potential
25%
Preterm Brain
25%
Temporal Effects
25%
Iba1
25%
Pre-oligodendrocyte
25%
Platelet-derived Growth Factor Receptor (PDGFR)
25%
Perinatal Brain Damage
25%
Neurological Injury
25%
Single Bolus
25%
Olig2
25%
Neurotherapeutics
25%
Erythropoietin Receptor
25%
EPO Receptor
25%
Developmental Disturbances
25%
Microgliosis
25%
Pathophysiological Changes
25%
Intrauterine Inflammation
25%
New Intervention
25%
Biphasic Regulation
25%
Medicine and Dentistry
Injury
100%
Chorioamnionitis
100%
Brain Injury
100%
Neuroinflammation
100%
Premature Labor
66%
Receptor Expression
66%
Immunoreactivity
66%
Erythropoietin
66%
Intrauterine Infection
66%
Interleukin 6
33%
Clinical Trial
33%
Lipopolysaccharide
33%
Cell Death
33%
Caspase 3
33%
Immunity
33%
Neuroprotective Agent
33%
Acivicin
33%
Perinatal Brain Damage
33%
Oligodendrocyte
33%
Gliosis
33%
Erythropoietin Receptor
33%
Gestational Age
33%
Pharmacology, Toxicology and Pharmaceutical Science
Injury
100%
Brain Injury
100%
Chorioamnionitis
100%
Nervous System Inflammation
100%
Premature Labor
66%
Erythropoietin
66%
Intrauterine Infection
66%
Interleukin 6
33%
Inflammation
33%
Lipopolysaccharide
33%
Receptor
33%
Caspase 3
33%
Clinical Trial
33%
Neuroprotective Agent
33%
Acivicin
33%
Erythropoietin Receptor
33%
Gliosis
33%
Neuroscience
Receptor Expression
100%
Erythropoietin
100%
Interleukin 6
50%
Lipopolysaccharide
50%
Gliosis
50%
Cell Death
50%
Brain Injury
50%
Caspase 3
50%
Neuroprotective Agent
50%
Oligodendrocyte
50%
Erythropoietin Receptor
50%
Interleukin 8
50%
INIS
brain
100%
injuries
100%
fetuses
100%
erythropoietin
42%
receptors
28%
interventions
28%
inflammation
28%
reduction
14%
damage
14%
risks
14%
regulations
14%
clinical trials
14%
infants
14%
delivery
14%
apoptosis
14%
disturbances
14%
birth
14%
dynamics
14%
lipopolysaccharides
14%